Purification is a bottleneck and a major cost factor in the production of antibodies. We set out to engineer a bifunctional fusion protein from two building blocks， Protein A and a hydrophobin， aiming at low-cost and scalable antibody capturing in solutions. Immunoglobulin-binding Protein A is widely used in affinity-based purification. The hydrophobin fusion tag， on the other hand， has been shown to enable purification by two-phase separation. Protein A was fused to two different hydrophobin tags， HFBI or II， and expressed transiently in Nicotiana benthamiana. The hydrophobins enhanced accumulation up to 35-fold， yielding up to 25% of total soluble protein. Both fused and nonfused Protein A accumulated in protein bodies. Hence， the increased yield could not be attributed to HFB-induced protein body formation. We also demonstrated production of HFBI-Protein A fusion protein in tobacco BY-2 suspension cells in 30 l scale， with a yield of 35 mg/l. Efficient partitioning to the surfactant phase confirmed that the fusion proteins retained the amphipathic properties of the hydrophobin block. The reversible antibody-binding capacity of the Protein A block was similar to the nonfused Protein A. The best-performing fusion protein was tested in capturing antibodies from hybridoma culture supernatant with two-phase separation. The fusion protein was able to carry target antibodies to the surfactant phase and subsequently release them back to the aqueous phase after a change in pH. This report demonstrates the potential of hydrophobin fusion proteins for novel applications， such as harvesting antibodies in solutions.